Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open Clinical Study to Evaluate the Protective Potential of EF192B Versus No Treatment

NCT06752460 is registered in ClinicalTrials.gov with Eurofarma Laboratorios S.A. as lead sponsor.

NCT NCT06752460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06752460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open Clinical Study to Evaluate the Protective Potential of EF192B Versus No Treatment
Lead sponsor
Eurofarma Laboratorios S.A.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
October 31, 2025
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin care, skin lesions